United Kingdom · Question · Written question
UIN 21131
Tixagevimab/cilgavimab
Original
Introduced
20 June 2022
Last action
30 June 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 June 2022
Summary
To ask the Secretary of State for Health and Social Care, when Evusheld will be available for eligible patients.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 June 2022
Written question
To ask the Secretary of State for Health and Social Care, when Evusheld will be available for eligible patients.
Source: Commons
30 June 2022
Answer
Evusheld was granted a conditional marketing authorisation by the Medicines and Healthcare products Regulatory Agency on 17 March 2022. However, the initial positive trial data for Evusheld was published prior to the emergence of the Omicron variant.The U...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-06-20/21131
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1471671
- uk · wq-1471671 · source updated 30 June 2022